Evaluation of fish skin gelatin hydrolysates inhibit dipeptidyl peptidase IV activity and their antidiabetic effect
碩士 === 中國醫藥大學 === 營養學系碩士班 === 101 === A novel approach for treatment of type 2 diabetes is the use of gut hormone glucagon-like peptide-1 (GLP-1), which possesses multi-functions such as the stimulation of insulin secretin and the blood glucose homeostasis. GLP-1 is a polypeptide that is rapidly ina...
Main Authors: | Meng-Chun Chen, 陳孟君 |
---|---|
Other Authors: | 徐國強 |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/33268620466846546364 |
Similar Items
-
Studies on porcine skin gelatin hydrolysates as dipeptidyl peptidase-IV inhibitors and their antidiabetic effect
by: Yu-Shan Tung, et al.
Published: (2012) -
Porcine skin gelatin hydrolysate as a dipeptidyl peptidase IV inhibitor improves glycemic control in streptozotocin-induced diabetic rats
by: Shih-Li Huang, et al.
Published: (2014-11-01) -
Fish skin gelatin hydrolysates as dipeptidyl peptidase IV inhibitors and glucagon-like peptide-1 stimulators improve glycaemic control in diabetic rats: A comparison between warm- and cold-water fish
by: Tzu-Yuan Wang, et al.
Published: (2015-12-01) -
Enzymatic production of protein hydrolysates from steelhead (Oncorhynchus mykiss) skin gelatin as inhibitors of dipeptidyl-peptidase IV and angiotensin-I converting enzyme
by: Imelda W.Y. Cheung, et al.
Published: (2017-01-01) -
Inhibition of Angiotensin I Converting Enzyme and Dipeptidyl Peptidase IV of Chlorella and Freshwater Clam Hydrolysates
by: Wu Yen-Ching, et al.
Published: (2014)